OAM
RDY icon

Origin Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Origin Asset Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,120,235
Closed -$10.1M – 136
2016
Q1 		$10.1M Hold
1,120,235
– – 0.71% 47
2015
Q4 		$10.4M Sell
1,120,235
-1,867,105
-63% -$20.4M 0.84% 39
2015
Q3 		$38.2M Buy
+2,987,340
New +$37.1M 3.16% 5
2014
Q2 		– Sell
-288,500
Closed -$2.53M – 116
2014
Q1 		$2.53M Buy
+288,500
New +$2.51M 0.17% 92

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Origin Asset Management's RDY Position: Q2 2016 in Review

Origin Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q2 2016, closing a stake of 1,120,235 shares — an estimated $10.1M sold.

Origin Asset Management first reported a position in RDY in Q1 2014 and held it in 4 quarters. The position peaked at $38.2M in Q3 2015. 157 funds tracked by Wall St. Rank hold RDY as of Q2 2016.

  • Origin Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q2 2016 after selling out during the quarter.
  • Origin Asset Management sold 1,120,235 Dr. Reddy's Laboratories shares in Q2 2016, an estimated $10.1M.
  • Origin Asset Management first reported a position in Dr. Reddy's Laboratories in Q1 2014 and held it in 4 quarters.
  • Origin Asset Management's Dr. Reddy's Laboratories position peaked at $38.2M in Q3 2015.
  • 157 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2016.

Based on Origin Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.